Literature DB >> 22371938

Early outcomes of chordal reconstruction for posterior mitral leaflet prolapse.

Kosaku Nishigawa1, Hiroki Takiuchi, Yoji Kubo, Hiroshi Kubo, Hisao Masaki, Kazuo Tanemoto.   

Abstract

We retrospectively reviewed 16 patients (7 men and 9 women, aged 36 to 77 years) who underwent mitral valve repair with chordal reconstruction for isolated posterior mitral leaflet prolapse. Preoperative echocardiography demonstrated moderate mitral regurgitation in 1, and severe regurgitation in 15. We routinely used expanded polytetrafluoroethylene sutures as artificial chords, and ring annuloplasty was performed in all cases (mean ring size, 30 ± 2 mm). After implanting the ring, the length of the artificial chords was adjusted repeatedly using saline solution. Early postoperative echocardiography at 7.1 ± 1.1 days after surgery showed mitral regurgitation grades reduced to none or trivial in 15/16 patients. One required reoperation for recurrent mitral regurgitation 1.5 years after surgery. In the other patients, intermediate-term echocardiography at 9.1 ± 10.1 months after surgery demonstrated that residual mitral regurgitation was less than mild. We concluded that chordal reconstruction is an effective and highly reproducible procedure for the repair of isolated posterior mitral leaflet prolapse. Artificial chords for the posterior mitral leaflet should not be too long, to avoid systolic anterior motion or recurrent mitral regurgitation after surgery.

Entities:  

Mesh:

Year:  2012        PMID: 22371938     DOI: 10.1177/0218492311433774

Source DB:  PubMed          Journal:  Asian Cardiovasc Thorac Ann        ISSN: 0218-4923


  1 in total

1.  Midterm Outcome of Mitral Valve Repair with Artificial Chordae for Only Posterior Leaflet Disease-Comparison with the Resectional Technique in a Single Institute.

Authors:  Hideaki Takai; Hiroaki Tanabe; Tsuyoshi Yamabe; Kenichi Sasaki; Hisayoshi Suma
Journal:  Ann Thorac Cardiovasc Surg       Date:  2015-08-28       Impact factor: 1.520

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.